Lipocine Cost Of Revenue from 2010 to 2025

LPCN Stock  USD 3.68  0.14  3.95%   
Lipocine Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to grow to about 9.3 M this year. During the period from 2010 to 2025, Lipocine Cost Of Revenue quarterly data regression pattern had sample variance of 9.1 T and median of  8,076,053. View All Fundamentals
 
Cost Of Revenue  
First Reported
2011-12-31
Previous Quarter
8.5 K
Current Value
1.9 M
Quarterly Volatility
1.3 M
 
Yuan Drop
 
Covid
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 11.8 M, as well as many indicators such as Price To Sales Ratio of 2.21, Dividend Yield of 0.0 or PTB Ratio of 1.3. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
  
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Latest Lipocine's Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Lipocine over the last few years. Cost of Revenue is found on Lipocine income statement and represents the costs associated with goods and services Lipocine provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Lipocine's Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Pretty Stable
   Cost Of Revenue   
       Timeline  

Lipocine Cost Of Revenue Regression Statistics

Arithmetic Mean8,348,222
Geometric Mean7,853,248
Coefficient Of Variation36.18
Mean Deviation2,305,731
Median8,076,053
Standard Deviation3,020,676
Sample Variance9.1T
Range11.7M
R-Value0.26
Mean Square Error9.1T
R-Squared0.07
Significance0.34
Slope163,369
Total Sum of Squares136.9T

Lipocine Cost Of Revenue History

20259.3 M
20247.4 M
202310.2 M
20228.6 M
20217.7 M
20209.7 M
20197.5 M

About Lipocine Financial Statements

Lipocine investors utilize fundamental indicators, such as Cost Of Revenue, to predict how Lipocine Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Cost Of Revenue7.4 M9.3 M
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share
2.097
Quarterly Revenue Growth
15.15
Return On Assets
(0.03)
Return On Equity
0.0004
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.